Clinical Trial Update: Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intraperitoneal oxaliplatin and fluorouracil for patients with peritoneal metastases from colorectal cancer; recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Metastasis

Drugs mentioned

• 5-Fluorouracil (5-FU)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Arjun Mittra | Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Peritoneum | Phase 1 | Status: RECRUITING